HT
MRNA icon

Headlands Technologies’s Moderna MRNA Stock Holding History

Headlands Technologies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-193
Closed -$23.4K – 1099
2023
Q2 		$23.4K Sell
193
-10,344
-98% -$1.38M 0.01% 545
2023
Q1 		$1.62M Buy
10,537
+8,200
+351% +$1.35M 1.08% 14
2022
Q4 		$420K Buy
+2,337
New +$382K 0.33% 91

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Headlands Technologies's MRNA Position: Q3 2023 in Review

Headlands Technologies sold out of Moderna (MRNA) in Q3 2023, closing a stake of 193 shares — an estimated $23.4K sold.

Headlands Technologies first reported a position in MRNA in Q4 2022 and held it in 3 quarters. The position peaked at $1.62M in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Headlands Technologies reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Headlands Technologies sold 193 Moderna shares in Q3 2023, an estimated $23.4K.
  • Headlands Technologies first reported a position in Moderna in Q4 2022 and held it in 3 quarters.
  • Headlands Technologies's Moderna position peaked at $1.62M in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Headlands Technologies's 13F filing for Q3 2023, filed 9 Nov 2023.